Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4387)
All Articles published online
|
Jun 15, 2002 (publication date) through Jun 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wang FS, Liu MX, Zhang B, Shi M, Lei ZY, Sun WB, Du QY, Chen JM. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i3/464.htm |
| Number | Citing Articles |
| 1 |
Li Lin, Yonggao Mu, Zhongping Chen. Preliminary study of local immunotherapy with autologous cytokine-induced killer cells for glioma patients. Chinese Journal of Clinical Oncology 2008; 5(4): 268 doi: 10.1007/s11805-008-0268-z
|
| 2 |
Xiao-Dong Li, Mei Ji, Xiao Zheng, Zhong-Hua Ning, Jun Wu, Binfeng Lu, Chang-Ping Wu, Jing-Ting Jiang. Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0215-0
|
| 3 |
Ying-Zhe Luo, Hong Zhu. Immunotherapy for advanced or recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(3): 405-424 doi: 10.4251/wjgo.v15.i3.405
Abstract(312) |
Core Tip(259) |
Full Article(HTML)(1888)
|
Full Article (PDF)-3180K(132)
|
Full Article (Word)-369K(35)
|
Audio-500K(6)
|
Peer-Review Report-238K(31)
|
Answering Reviewers-259K(32)
|
Times Cited (0)
|
Total Visits (4429)
|
Open
|
| 4 |
Qiang Zhang, Xiao-yan Liu, Teng Zhang, Xin-feng Zhang, Lin Zhao, Fei Long, Zhuang-kai Liu, En-hua Wang. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology. Human Immunology 2015; 76(5): 385 doi: 10.1016/j.humimm.2014.09.021
|
| 5 |
Xiang Wang, Song Tang, Xiang Cui, Jinwei Yang, Chunyu Geng, Cong Chen, Ning Zhou, Yumin Li. Cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer. Medicine 2018; 97(36): e12230 doi: 10.1097/MD.0000000000012230
|
| 6 |
Michael P Johnston, Salim I Khakoo. Immunotherapy for hepatocellular carcinoma: Current and future. World Journal of Gastroenterology 2019; 25(24): 2977-2989 doi: 10.3748/wjg.v25.i24.2977
|
| 7 |
Je Il Ryu, Myung Hoon Han, Jin Hwan Cheong, Jae Min Kim, Choong Hyun Kim. Current Update of Adoptive Immunotherapy Using Cytokine-Induced Killer Cells to Eliminate Malignant Gliomas. Immunotherapy 2017; 9(5): 411 doi: 10.2217/imt-2017-0003
|
| 8 |
Dengqiang Wu, Yujie Li. Application of adoptive cell therapy in hepatocellular carcinoma. Immunology 2023; 170(4): 453 doi: 10.1111/imm.13677
|
| 9 |
HEJIN JIA, YAPING TIAN, CHAO GUANG JIANG, WEIDONG HAN. Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy. Experimental and Therapeutic Medicine 2016; 11(5): 1601 doi: 10.3892/etm.2016.3102
|
| 10 |
Ming Shi, Bing Zhang, Zi-Rong Tang, Zhou-Yun Lei, Hui-Fen Wang, Yong-Yi Feng, Zhen-Ping Fan, Dong-Ping Xu, Fu-Sheng Wang. Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(8): 1146-1151 doi: 10.3748/wjg.v10.i8.1146
|
| 11 |
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Michail Vailas, Dimitrios Moris, Efthymios Gkotsis, Stylianos Kykalos, Michalis V. Karamouzis, Dimitrios Schizas. Immunotherapy for Hepatocellular Carcinoma: A 2021 Update. Cancers 2020; 12(10): 2859 doi: 10.3390/cancers12102859
|
| 12 |
Yuki HOSHINO, Satoshi TAKAGI, Tomohiro OSAKI, Masahiro OKUMURA, Toru FUJINAGA. Phenotypic Analysis and Effects of Sequential Administration of Activated Canine Lymphocytes on Healthy Beagles. Journal of Veterinary Medical Science 2008; 70(6): 581 doi: 10.1292/jvms.70.581
|
| 13 |
Zheng Xiao, Cheng-qiong Wang, Ming-hua Zhou, Na-na Li, Yong-ping Sun, Yu-zhi Wang, Shi-yu Liu, Hong-song Yu, Cheng-wen Li, Xian-tao Zeng, Ling Chen, Xin-sheng Yao, Ji-hong Feng. The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/9081938
|
| 14 |
Sharmilan Thanendrarajan, Michael Nowak, Hinrich Abken, Ingo G.H. Schmidt-Wolf. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?. Leukemia Research 2011; 35(9): 1136 doi: 10.1016/j.leukres.2011.05.005
|
| 15 |
Assel Issabekova, Marzhan Zhumabekova, Madina Zhunussova, Vyacheslav Ogay. The Crosstalk Between Dendritic Cells, Cytokine-Induced Killer Cells And Cancer Cells From The Perspective Of Combination Therapy. Russian Open Medical Journal 2021; 10(2) doi: 10.15275/rusomj.2021.0209
|
| 16 |
Jingting Jiang, Changping Wu, Binfeng Lu. Cytokine-induced killer cells promote antitumor immunity. Journal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-83
|
| 17 |
YONG ZHANG, YONGPING SONG, QUANLI GAO. Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review. Oncology Letters 2015; 10(2): 883 doi: 10.3892/ol.2015.3296
|
| 18 |
De-Sheng Weng, Jun Zhou, Qi-Ming Zhou, Ming Zhao, Qi-Jing Wang, Li-Xi Huang, Yong-Qiang Li, Shi-Ping Chen, Pei-Hong Wu, Jian-Chuan Xia. Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas. Journal of Immunotherapy 2008; 31(1): 63 doi: 10.1097/CJI.0b013e31815a121b
|
| 19 |
Ji Sung Kim, Yong Guk Kim, Minji Pyo, Hong Kyung Lee, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells. Immune Network 2015; 15(2): 58 doi: 10.4110/in.2015.15.2.58
|
| 20 |
Ming Shi, Junliang Fu, Feng Shi, Bin Zhang, Zirong Tang, Zheng Zhang, Hui Zhang, Lei Jin, Liming Chen, Huifeng Wang, Sheikh Mohammad Fazle Akbar, Fu‐Sheng Wang. Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine‐induced killer cell transfusion. Liver International 2009; 29(3): 466 doi: 10.1111/j.1478-3231.2008.01861.x
|
| 21 |
Li-Wu Lin, Xue-Ying Lin, Yi-Mi He, Shang-Da Gao, Xiao-Dong Lin. Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application. World Journal of Gastroenterology 2003; 9(5): 941-945 doi: 10.3748/wjg.v9.i5.941
|
| 22 |
Hansong Du, Jia Yang, Ying Zhang. Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06860-y
|
| 23 |
Tong-Dong Shi, Yu-Zhang Wu, Zheng-Cai Jia, Wei Zhou, Li-Yun Zou. Therapeutic polypeptides based on HBcAg<sub>18-27</sub> CTL epitope can induce antigen-specific CD<sub>8</sub><sup>+</sup> CTL-mediated cytotoxicity in HLA-A2 transgenic mice. World Journal of Gastroenterology 2004; 10(8): 1222-1226 doi: 10.3748/wjg.v10.i8.1222
|
| 24 |
TAO WU, CÉLINE LEBOEUF, SARAH DURAND, BIN SU, MARINA DESCHAMPS, XIAOWEN ZHANG, CHRISTOPHE FERRAND, PATRICK PESSAUX, ERIC ROBINET. Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma. Molecular Medicine Reports 2016; 13(3): 2645 doi: 10.3892/mmr.2016.4811
|
| 25 |
Himanshu Tillu, Ganji Purnachandra Nagaraju. Role of Transcription Factors in Gastrointestinal Malignancies. 2017; : 5 doi: 10.1007/978-981-10-6728-0_2
|
| 26 |
Armita M. Gorabi, Saeideh Hajighasemi, Thozhukat Sathyapalan, Amirhossein Sahebkar. Cell transfer‐based immunotherapies in cancer: A review. IUBMB Life 2020; 72(4): 790 doi: 10.1002/iub.2180
|
| 27 |
Fen Huang, Bo Wang, Jiangzheng Zeng, Shenggang Sang, Junhua Lei, Yanda Lu. MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.7951
|
| 28 |
Xiao-Dong Li, Bin Xu, Jun Wu, Mei Ji, Bei-Hua Xu, Jing-Ting Jiang, Chang-Ping Wu. Review of Chinese clinical trials on CIK cell treatment for malignancies. Clinical and Translational Oncology 2012; 14(2): 102 doi: 10.1007/s12094-012-0768-4
|
| 29 |
Seok-Gu Kang, Sin Soo Jeun, Jung Yeon Lim, Do Sung Yoo, Pil Woo Huh, Kyung Souk Cho, Dal Soo Kim, Hyung-Jin Shin, Jong Hyun Kim, Moon Chan Kim, Joon Ki Kang. Cytotoxicity of rat marrow stromal cells against malignant glioma cells. Child's Nervous System 2005; 21(7): 528 doi: 10.1007/s00381-005-1216-3
|
| 30 |
Dong Hui, Li Qiang, Wang Jian, Zhang Ti, Kong Da-Lu. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma. Digestive and Liver Disease 2009; 41(1): 36 doi: 10.1016/j.dld.2008.04.007
|
| 31 |
Alice Pievani, Camilla Belussi, Christian Klein, Alessandro Rambaldi, Josée Golay, Martino Introna. Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies. Blood 2011; 117(2): 510 doi: 10.1182/blood-2010-06-290858
|
| 32 |
Jian-Lin Chen, Xiang-Ming Lao, Xiao-Jun Lin, Li Xu, Bo-Kang Cui, Jun Wang, Guo-He Lin, Ze-Yu Shuang, Yi-Ze Mao, Xin Huang, Jing-Ping Yun, Jie-Tian Jin, Sheng-Ping Li. Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection. Medicine 2016; 95(5): e2665 doi: 10.1097/MD.0000000000002665
|
| 33 |
Zheng Xiao, Cheng-qiong Wang, Ming-hua Zhou, Na-na Li, Shi-yu Liu, Yue-juan He, Yu-zhi Wang, Ji-hong Feng, Xin-sheng Yao, Ling Chen, Bin Ma, Song Yu, Xian-tao Zeng, Cheng-wen Li, Jie Ding. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials. International Immunopharmacology 2018; 61: 363 doi: 10.1016/j.intimp.2018.06.012
|
| 34 |
Maria A. González‐Carmona, Angela Märten, Per Hoffmann, Carlo Schneider, Elisabeth Sievers, Ingo G. H. Schmidt‐Wolf, Tilman Sauerbruch, Wolfgang H. Caselmann. Patient‐derived dendritic cells transduced with an a‐fetoprotein‐encoding adenovirus and co‐cultured with autologous cytokine‐induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. Liver International 2006; 26(3): 369 doi: 10.1111/j.1478-3231.2005.01235.x
|
| 35 |
Ran Chen, Xin Deng, Haochen Wu, Peichun Peng, Bin Wen, Fuyin Li, Fenfen Li. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: A systematic review and meta-analysis. International Immunopharmacology 2014; 22(2): 451 doi: 10.1016/j.intimp.2014.07.019
|
| 36 |
Tian-Tian Li, Jing Sun, Quan Wang, Wen-Gang Li, Wei-Ping He, Rui-Chuang Yang, Xue-Zhang Duan. The effects of stereotactic body radiotherapy on peripheral natural killer and CD3+CD56+ NKT-like cells in patients with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 240 doi: 10.1016/j.hbpd.2020.12.015
|
| 37 |
ZHENG XIAO, CHENG-QIONG WANG, JI-HONG FENG, MING-HUA ZHOU, YU-ZHI WANG, NA-NA LI, YONG-PING SUN, SHI-YU LIU, XIN-SHENG YAO, CHENG-WEN LI, BIN MA, JIE DING, LING CHEN. Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non–small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials. Cytotherapy 2019; 21(2): 125 doi: 10.1016/j.jcyt.2018.10.011
|
| 38 |
Aaron J. Smith, John Oertle, Dino Prato. Autologous Natural Killer Cell/Natural Killer T Cell Immunotherapy of Malignant Diseases. Open Journal of Medical Microbiology 2014; 4(03): 192 doi: 10.4236/ojmm.2014.43021
|
| 39 |
Ana F. Trueba, Thomas Ritz, Gabriel Trueba. Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health. Advances in Experimental Medicine and Biology 2016; 874: 263 doi: 10.1007/978-3-319-20215-0_13
|
| 40 |
Céline Leboeuf, Laurent Mailly, Tao Wu, Gaetan Bour, Sarah Durand, Nicolas Brignon, Christophe Ferrand, Christophe Borg, Pierre Tiberghien, Robert Thimme, Patrick Pessaux, Jacques Marescaux, Thomas F. Baumert, Eric Robinet. In Vivo Proof of Concept of Adoptive Immunotherapy for Hepatocellular Carcinoma Using Allogeneic Suicide Gene-modified Killer Cells. Molecular Therapy 2014; 22(3): 634 doi: 10.1038/mt.2013.277
|
| 41 |
Ming Zhao, Hui Huang, Feng He, Xiangsheng Fu. Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1188277
|
| 42 |
BIN CHEN, LIFEN LIU, HAIYAN XU, YIJIN YANG, LING ZHANG, FENGCHUN ZHANG. Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer. Experimental and Therapeutic Medicine 2015; 9(3): 1063 doi: 10.3892/etm.2015.2217
|
| 43 |
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
|
| 44 |
Yazheng Dang, Tao Qi, Hongxiang Gao, Shigao Huang. Radiotherapy combined with cytokine-induced killer cell therapy for liver metastasis from rectal cancer. Medicine 2019; 98(43): e17636 doi: 10.1097/MD.0000000000017636
|
| 45 |
Maria Tagliamonte, Angela Mauriello, Beatrice Cavalluzzo, Concetta Ragone, Carmen Manolio, Annacarmen Petrizzo, Luigi Buonaguro. Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches. Cancer Letters 2020; 473: 25 doi: 10.1016/j.canlet.2019.12.029
|
| 46 |
J.-H. Zhong, L. Ma, L.-C. Wu, W. Zhao, W.-P. Yuan, F.-X. Wu, Z.-M. Zhang, S. Huang, X. M. You, L.-Q. Li. Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review. International Journal of Clinical Practice 2012; 66(1): 21 doi: 10.1111/j.1742-1241.2011.02814.x
|
| 47 |
Gbemisola Lawal, Yao Xiao, Amir A. Rahnemai-Azar, Diamantis I. Tsilimigras, Ming Kuang, Anargyros Bakopoulos, Timothy M. Pawlik. The Immunology of Hepatocellular Carcinoma. Vaccines 2021; 9(10): 1184 doi: 10.3390/vaccines9101184
|
| 48 |
Isabella Faraoni, Andrea Cottarelli, Anna Giuliani, Laura Bonmassar, Lorena Rossi, Enzo Bonmassar. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro. Journal of Immunological Methods 2005; 305(2): 162 doi: 10.1016/j.jim.2005.07.015
|
| 49 |
Laeza Alves Sampaio, Lícia Tairiny Santos Pina, Mairim Russo Serafini, Débora dos Santos Tavares, Adriana Gibara Guimarães. Antitumor Effects of Carvacrol and Thymol: A Systematic Review. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.702487
|
| 50 |
Yingjun Xie, Yien Xiang, Jiyao Sheng, Dan Zhang, Xiaoxiao Yao, Yongsheng Yang, Xuewen Zhang. Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/8740976
|
| 51 |
M Introna, M Franceschetti, A Ciocca, G Borleri, E Conti, J Golay, A Rambaldi. Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation. Bone Marrow Transplantation 2006; 38(9): 621 doi: 10.1038/sj.bmt.1705503
|
| 52 |
Jian Wang, Min He, Weijin Shi, Huifang Sha, Jiuxian Feng, Shujun Wang, Ying Wang. Inducible Costimulator (ICOS) Enhances the Cytolytic Activity of Cytokine-Induced Killer Cells Against Gallbladder CancerIn VitroandIn Vivo. Cancer Investigation 2009; 27(3): 244 doi: 10.1080/07357900802239124
|
| 53 |
Lili Wang, Yongxiang Yi, Dandan Yin, Zhenxian Zhou, Jing Fan, Wei Ye, Wei Zhao. Augmented CD3+CD8+ and CD3+CD56− cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumor. Cytotherapy 2016; 18(4): 581 doi: 10.1016/j.jcyt.2015.11.021
|
| 54 |
Solmaz Shirjang, Nazila Alizadeh, Behzad Mansoori, Ata Mahmoodpoor, Hossein Samadi Kafil, Mohammad Hojjat‐Farsangi, Mehdi Yousefi. Promising immunotherapy: Highlighting cytokine‐induced killer cells. Journal of Cellular Biochemistry 2019; 120(6): 8863 doi: 10.1002/jcb.28250
|
| 55 |
Xucang Wei, Xinhui Zhai, Wenli Zhao, Didi Yang, Xiurui Han. Research on the biological activity and anti-tumor effect against lymphoma cells of DC-CIK cells. The Chinese-German Journal of Clinical Oncology 2008; 7(11): 666 doi: 10.1007/s10330-008-0084-1
|
| 56 |
E. V. Abakushina, Yu. V. Gel’m, E. Yu. Lyssuk. Activation of lymphocytes in vitro for immunotherapy of patients with melanoma. Medical alphabet 2021; 1(31): 13 doi: 10.33667/2078-5631-2021-31-13-18
|
| 57 |
Dario Sangiolo, Emanuela Martinuzzi, Maja Todorovic, Katiuscia Vitaggio, Antonella Vallario, Noela Jordaney, Fabrizio Carnevale-Schianca, Antonio Capaldi, Massimo Geuna, Laura Casorzo, Richard A. Nash, Massimo Aglietta, Alessandro Cignetti. Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers. International Immunology 2008; 20(7): 841 doi: 10.1093/intimm/dxn042
|
| 58 |
Alice Pievani, Gianmaria Borleri, Daniela Pende, Lorenzo Moretta, Alessandro Rambaldi, Josée Golay, Martino Introna. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood 2011; 118(12): 3301 doi: 10.1182/blood-2011-02-336321
|
| 59 |
Farbod Ghobadinezhad, Zhila Izadi, Marzieh Ebrahimi, Nima Rezaei. . Interdisciplinary Cancer Research 2023; doi: 10.1007/16833_2022_105
|
| 60 |
Hwan Mook Kim, Jaeseung Lim, Yeo Dae Yoon, Ji Mi Ahn, Jong Soon Kang, Kiho Lee, Song-Kyu Park, Yu Jin Jeong, Jin Mi Kim, Gyoonhee Han, Kyu-Hwan Yang, Yeon Jin Kim, Youngsoo Kim, Sang-Bae Han. Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma. International Immunopharmacology 2007; 7(13): 1793 doi: 10.1016/j.intimp.2007.08.007
|
| 61 |
Jianhua Liu, Lu Wang, Yaoling Wang, Wenjie Zhang, Yilin Cao, Tao Lu. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion. PLOS ONE 2017; 12(4): e0175704 doi: 10.1371/journal.pone.0175704
|
| 62 |
Liangrong Shi, Qi Zhou, Jun Wu, Mei Ji, Guojun Li, Jingting Jiang, Changping Wu. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunology, Immunotherapy 2012; 61(12): 2251 doi: 10.1007/s00262-012-1289-2
|
| 63 |
Yeon Jin Kim, Ji Yeon Kim, Ji Su Kim, Hwa Kyung Kim, Hong Kyung Lee, Sang-Bae Han. Optimization of Cytokine-Induced Killer Cell Generation from Mouse Spleen Cells. Drug Targets and Therapeutics 2024; 3(1): 31 doi: 10.58502/DTT.23.0032
|
| 64 |
Juhua Zhou. Advances and Prospects in Cancer Immunotherapy. New Journal of Science 2014; 2014: 1 doi: 10.1155/2014/745808
|
| 65 |
Chan-Ran Park, Hye-Ri Bae, Ga-Young Lee, Chang-Gue Son, Jung-Hyo Cho, Chong-Kwan Cho, Nam-Hun Lee. Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1203379
|
| 66 |
Angela R. Elia, Paola Circosta, Dario Sangiolo, Chiara Bonini, Loretta Gammaitoni, Sara Mastaglio, Pietro Genovese, Massimo Geuna, Fabio Avolio, Giorgio Inghirami, Corrado Tarella, Alessandro Cignetti. Cytokine-Induced Killer Cells Engineered with Exogenous T-Cell Receptors Directed Against Melanoma Antigens: Enhanced Efficacy of Effector Cells Endowed with a Double Mechanism of Tumor Recognition. Human Gene Therapy 2015; 26(4): 220 doi: 10.1089/hum.2014.112
|
| 67 |
Zheng Peng, Wentao Liang, Zexue Li, Yingxin Xu, Lin Chen. Interleukin‐15‐transferred cytokine‐induced killer cells elevated anti‐tumor activity in a gastric tumor‐bearing nude mice model. Cell Biology International 2016; 40(2): 204 doi: 10.1002/cbin.10553
|
| 68 |
Jing Wang, Lingxin Feng, Linwei Zhang. Combining cellular immunotherapy was an optional choice for unresectable advanced HCC: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2021; 45(1): 101440 doi: 10.1016/j.clinre.2020.04.010
|
| 69 |
Xiaofeng Li, Dong Dai, Xiuyu Song, Jianjing Liu, Lei Zhu, Wengui Xu. A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2014; 38(5): 583 doi: 10.1016/j.clinre.2014.04.010
|
| 70 |
Kenichiro Hasumi, Yukimasa Aoki, Ryuko Wantanabe, Dean L Mann. Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy. OncoImmunology 2013; 2(10): e26381 doi: 10.4161/onci.26381
|
| 71 |
Somayeh Ashrafi, Reza Shapouri, Ahmad Shirkhani, Mehdi Mahdavi. Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model. Biomedicine & Pharmacotherapy 2018; 104: 45 doi: 10.1016/j.biopha.2018.05.002
|
| 72 |
Stefan Mehrle, Susanne Frank, Jan Schmidt, Ingo GH Schmidt-Wolf, Angela Marten. SAP and SLAM expression in anti-CD3 activated lymphocytes correlates with cytotoxic activity. Immunology and Cell Biology 2005; 83(1): 33 doi: 10.1111/j.1440-1711.2004.01302.x
|
| 73 |
Ram Aasarey, Kajal Yadav, Brijendra Kumar Kashyap, Sarit Prabha, Pramod Kumar, Anil Kumar, Janne Ruokolainen, Kavindra Kumar Kesari. Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways. ACS Pharmacology & Translational Science 2023; 6(12): 1801 doi: 10.1021/acsptsci.3c00216
|
| 74 |
Ming Shi, Junliang Fu, Feng Shi, Bin Zhang, Zirong Tang, Lei Jin, Zhenping Fan, Zheng Zhang, Liming Chen, Huifeng Wang, George K.K. Lau, Fu-Sheng Wang. Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clinical Immunology 2009; 132(1): 43 doi: 10.1016/j.clim.2009.03.001
|
| 75 |
M. Introna. CIK as therapeutic agents against tumors. Journal of Autoimmunity 2017; 85: 32 doi: 10.1016/j.jaut.2017.06.008
|
| 76 |
Martino Introna, Fabio Correnti. Innovative Clinical Perspectives for CIK Cells in Cancer Patients. International Journal of Molecular Sciences 2018; 19(2): 358 doi: 10.3390/ijms19020358
|
| 77 |
Stefan Mehrle, Susanne Frank, Jan Schmidt, Ingo GH Schmidt‐Wolf, Angela Märten. SAP and SLAM expression in anti‐CD3 activated lymphocytes correlates with cytotoxic activity. Immunology & Cell Biology 2005; 83(1): 33 doi: 10.1111/j.1440-1711.2005.01302.x
|
| 78 |
Nazanin Momeni Roudsari, Naser-Aldin Lashgari, Saeideh Momtaz, Amir Hossein Abdolghaffari. Cancer Immunology. 2020; : 241 doi: 10.1007/978-3-030-57949-4_9
|
| 79 |
Yu-Peng Hong, Zi-Duo Li, Pankaj Prasoon, Qi Zhang. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World Journal of Hepatology 2015; 7(7): 980-992 doi: 10.4254/wjh.v7.i7.980
|
| 80 |
YA-FENG WANG, PATRICIA E. KUNDA, JIAN-WEI LIN, HAN WANG, XUE-MEI CHEN, QIU-LING LIU, TAO LIU. Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cells. Oncology Reports 2013; 29(5): 1841 doi: 10.3892/or.2013.2315
|
| 81 |
Tobi L. Schmidt, Robert S. Negrin, Christopher H. Contag. A killer choice for cancer immunotherapy. Immunologic Research 2014; 58(2-3): 300 doi: 10.1007/s12026-014-8507-2
|